001     302030
005     20250622021240.0
024 7 _ |a 10.1186/s13014-025-02671-2
|2 doi
024 7 _ |a pmid:40517223
|2 pmid
024 7 _ |a pmc:PMC12167587
|2 pmc
024 7 _ |a altmetric:178104892
|2 altmetric
037 _ _ |a DKFZ-2025-01221
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Dehelean, Diana-Coralia
|b 0
245 _ _ |a Evaluating large language models as an educational tool for meningioma patients: patient and clinician perspectives.
260 _ _ |a London
|c 2025
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1750141086_24492
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The study explores the potential of ChatGPT, an advanced large language model (LLM) by OpenAI, in educating patients about meningioma, a common type of brain tumor. While ChatGPT has generated significant debate regarding its utility and ethics, its growing popularity suggests that patients may increasingly use such tools for medical information. The study specifically examines how patients who have undergone radiation therapy for meningioma perceive the information generated by ChatGPT, integrating both patient feedback and clinical assessment.Eight meningioma-related questions on diagnosis, treatment options, and radiation therapy were posed to ChatGPT 4. A questionnaire with these responses and feedback items was developed to assess utility, accuracy, clarity, and alignment with patients' experiences. Nine clinicians first rated each response's relevance, correctness, and completeness on a five-point Likert scale. Subsequently, 28 patients with meningioma completed the questionnaire during their first follow-up visit (three months post-radiation therapy). Finally, the same questions were presented to three other large language models (ChatGPT 4o mini, Gemini Free, Gemini Advanced), and seven blinded clinicians rated each model's responses before selecting the most accurate, eloquent, and comprehensive overall.The study cohort included 28 meningioma patients, mostly female, with a median age of 60 years. Most patients found the information clear, accurate, and reflective of their experiences, with 60% willing to use ChatGPT for future inquiries. Clinicians rated the relevance and correctness of the information highly, although completeness was rated slightly lower, particularly for questions about specific radiation therapy details and side effects. ChatGPT 4 and its newer version ChatGPT 4o mini received the highest, nearly identical scores among the four LLMs evaluated, while Gemini Free scored the lowest in clinician assessments.ChatGPT demonstrates potential as a supplementary educational tool for meningioma patients, though some areas may require improvement, particularly in providing comprehensive information. The study highlights the potential for integrating AI in patient education, while also noting the need for clinical oversight to ensure accuracy and completeness.LMU ethics vote nr.: 23-0742.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a ChatGPT
|2 Other
650 _ 7 |a Large language model
|2 Other
650 _ 7 |a Meningioma
|2 Other
650 _ 7 |a Patient experience
|2 Other
650 _ 7 |a Radiation therapy
|2 Other
650 _ 7 |a Stereotactic radiosurgery
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Meningioma: radiotherapy
|2 MeSH
650 _ 2 |a Meningioma: psychology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Meningeal Neoplasms: radiotherapy
|2 MeSH
650 _ 2 |a Meningeal Neoplasms: psychology
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Surveys and Questionnaires
|2 MeSH
650 _ 2 |a Patient Education as Topic: methods
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Language
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Large Language Models
|2 MeSH
700 1 _ |a Maier, Sebastian H
|b 1
700 1 _ |a Altay-Langguth, Alev
|b 2
700 1 _ |a Nitschmann, Alexander
|b 3
700 1 _ |a Schmeling, Michael
|b 4
700 1 _ |a Fleischmann, Daniel
|0 P:(DE-He78)bc38e646ac503a9cfbb96025c129189d
|b 5
700 1 _ |a Rogowski, Paul
|b 6
700 1 _ |a Trapp, Christian
|b 7
700 1 _ |a Corradini, Stefanie
|b 8
700 1 _ |a Belka, Claus
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Schönecker, Stephan
|b 10
700 1 _ |a Marschner, Sebastian N
|b 11
773 _ _ |a 10.1186/s13014-025-02671-2
|g Vol. 20, no. 1, p. 101
|0 PERI:(DE-600)2224965-5
|n 1
|p 101
|t Radiation oncology
|v 20
|y 2025
|x 1748-717X
909 C O |o oai:inrepo02.dkfz.de:302030
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)bc38e646ac503a9cfbb96025c129189d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b RADIAT ONCOL : 2022
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:44:48Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:44:48Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-04-10T15:44:48Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-18
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-18
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-18
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-18
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-18
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-18
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21